BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 350227)

  • 1. Mode of action of 5-fluorocytosine.
    Diasio RB; Bennett JE; Myers CE
    Biochem Pharmacol; 1978 Mar; 27(5):703-7. PubMed ID: 350227
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacology of the fluoropyrimidines.
    Myers CE
    Pharmacol Rev; 1981 Mar; 33(1):1-15. PubMed ID: 6170079
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of 5-fluorocytosine on the temperature profile of Candida albicans.
    Lemos-Carolino M; Madeira-Lopes A
    Sabouraudia; 1984; 22(4):351-4. PubMed ID: 6390737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of 5-fluorocytosine.
    Waldorf AR; Polak A
    Antimicrob Agents Chemother; 1983 Jan; 23(1):79-85. PubMed ID: 6338821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W; Heins S
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action mechanism of 5-fluorocytosine. IV. Morphological observation and development of the resistant cells].
    Arai T; Mikami Y; Kawada T; Masuda K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):257. PubMed ID: 765563
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of flucytosine on the germination of Candida albicans.
    Wain WH; Polak A
    Postgrad Med J; 1979 Sep; 55(647):671-3. PubMed ID: 392482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL; Beneke ES; Rogers AL; Soll DR
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
    Pawlik B; Barylak J
    Med Dosw Mikrobiol; 1977; 29(4):301-7. PubMed ID: 340821
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspective on the design and biochemical pharmacology of inhibitors of thymidylate synthetase.
    Santi DV
    J Med Chem; 1980 Feb; 23(2):103-11. PubMed ID: 6987403
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological changes in yeasts as a result of the action of 5-fluorocytosine.
    Arai T; Mikami Y; Yokoyama K; Kawata T; Masuda K
    Antimicrob Agents Chemother; 1977 Aug; 12(2):255-60. PubMed ID: 332075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymidylate synthase and fluorouracil.
    Ivanetich KM; Santi DV
    Adv Exp Med Biol; 1988; 244():113-24. PubMed ID: 3150251
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Synergism between 5-fluorocytosine and polyene antibiotics.
    Polak A
    Pathol Microbiol (Basel); 1975; 42(4):234-5. PubMed ID: 778764
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Kerridge D
    Antimicrob Agents Chemother; 1984 Oct; 26(4):570-4. PubMed ID: 6393861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Markie D; Kwon-Chung KJ
    Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.